Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Second-Line Treatments for Anxiety When SSRIs and SNRIs Fail

Pharmacological Second-Line Options

  • The Canadian Clinical Practice Guidelines recommend benzodiazepines (alprazolam, bromazepam, clonazepam) as second-line agents for rapid anxiety relief 1, 2, 4
  • Pregabalin has demonstrated efficacy as a second-line treatment for anxiety disorders, according to the Canadian guidelines 2
  • Gabapentin is recommended as a second-line option by Canadian guidelines for patients with comorbid pain conditions 1
  • The Canadian CPG notes negative evidence for quetiapine in social anxiety disorder 1

Non-Pharmacological Options

  • Cognitive Behavioral Therapy (CBT) is strongly recommended for anxiety disorders by the Canadian Clinical Practice Guidelines 1, 2, 3
  • Individual CBT is preferred over group therapy due to superior clinical effectiveness, as recommended by the Canadian Clinical Practice Guidelines 1
  • Self-help CBT with professional support is an alternative for patients who decline face-to-face therapy, according to the Canadian Clinical Practice Guidelines 1

Treatment Approach

  • Combination therapy (medication plus CBT) often yields better results than either approach alone, as recommended by the Canadian Clinical Practice Guidelines 1, 3
  • Regular monitoring by a physician with expertise in anxiety disorders is essential for evaluating treatment response, according to the Canadian Clinical Practice Guidelines 1